1999
DOI: 10.1016/s0049-3848(98)00165-0
|View full text |Cite
|
Sign up to set email alerts
|

Measurement of Prethrombotic Markers in the Assessment of Acquired Hypercoagulable States

Abstract: The combination of selected fibrinolytic and coaguAbstract lation measurements is useful for the detection of a hypercoagulable state in conditions characterHypercoagulable states can be detected by meaized by a risk of thrombosis. © 1999 Elsevier Scisuring activation peptides, enzyme-inhibitor comence Ltd. All rights reserved. plexes, and fibrin/fibrinogen degradation products, which are markers of hemostatic activation. A series of these prethrombotic markers has been eval-

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

6
40
0
1

Year Published

2000
2000
2021
2021

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 68 publications
(47 citation statements)
references
References 33 publications
6
40
0
1
Order By: Relevance
“…[22][23][24] The half-life, approximately 90 minutes, makes its measurement in plasma more reliable than other markers for ongoing coagulation, such as thrombin-antithrombin complexes. However, whether F1ϩ2 provides a useful marker of atherosclerosis is still debated.…”
Section: Discussionmentioning
confidence: 99%
“…[22][23][24] The half-life, approximately 90 minutes, makes its measurement in plasma more reliable than other markers for ongoing coagulation, such as thrombin-antithrombin complexes. However, whether F1ϩ2 provides a useful marker of atherosclerosis is still debated.…”
Section: Discussionmentioning
confidence: 99%
“…These conditions display a significant increase both of the parameters indicating clotting activation (F1+2, TAT complex, FPA), and the markers of fibrinolysis (plasmin-alpha 2 antiplasmin complex and D-dimer). 62 In another report, antithrombin III (ATIII), D-dimer (DD), fibrinogen (F) in association to prothrombin time (PT), partial thromboplastin time (PTT) and platelet count, have been recorded in 286 patients with a new primary lung cancer, in order to evaluate the potential prognostic implications of coagulation disorders in this malignancy. The authors have shown that lower values of PT, in addition to higher values of F and DD were significantly predictive of an adverse outcome.…”
Section: Laboratory F Indingsmentioning
confidence: 99%
“…Thrombin is a serine proteinase and is involved in hemostatic and thrombotic roles, from promotion and inhibition of clotting, to fibrinolysis, platelet activation, and inflammation. In the past, biochemical signs of coagulation activation in the acute phase of unstable angina or acute myocardial infarction (AMI) were demonstrated [1,2] and blood clotting activation markers were found to be independent risk factors for recurrence and long-term mortality [3][4][5][6]. In the last years the diffuse use of PCI and stenting stimulated several studies investigating primarily the role of platelet hyper-reactivity in determining clinical outcome [7,8].…”
Section: Introductionmentioning
confidence: 99%